Full Press Release Details
What is NETosis?
In the first video of our NETs educational series, Dr Andrew Retter , Volition’s Chief Medical Officer, discusses the process of NETosis, its role in sepsis and the development of Volition’s H3.1 assay.
NETosis is the release of neutrophil extracellular traps (NETs), where neutrophils eject DNA to trap pathogens. Traditionally, neutrophils were only known for phagocytosis, but research has shown that they can also degranulate and release NETs, which can capture bacteria, viruses and fungi.
Explaining how Nu.Q ® H3.1 acts as a marker for NETosis, aiding in the diagnosis, monitoring and potential treatment of sepsis, this video dives into the biological mechanisms of NET release, showing how NETs can create both positive and harmful responses.
Click here for the next video in our series: Clinical Evidence and Upcoming Studies
Related Articles
• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states
Data Showing the Prognostic Value of its Nu.Q® Cancer Test
Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states
• Share
• Tweet
• Share on Facebook
• Share
Subscribe for Volition product updates .
Or, click here for Investor Updates and press releases .
" * " indicates required fields